This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2010 Aug;85(8):608.

doi: 10.1002/ajh.21719.

Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient

Cristina Papayannidis¹, Ilaria Iacobucci, Maria Chiara Abbenante, Antonio Curti, Stefania Paolini, Sarah Parisi, Michele Baccarani, Giovanni Martinelli

Affiliations

PMID: 20658590
DOI: 10.1002/ajh.21719

Free article

Case Reports

Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient

Cristina Papayannidis et al. Am J Hematol. 2010 Aug.

Free article

. 2010 Aug;85(8):608.

doi: 10.1002/ajh.21719.

Authors

Cristina Papayannidis¹, Ilaria Iacobucci, Maria Chiara Abbenante, Antonio Curti, Stefania Paolini, Sarah Parisi, Michele Baccarani, Giovanni Martinelli

Affiliation

¹ Institute of Hematology/Oncology "L. and A. Seràgnoli," S.Orsola-Malpighi Hospital, University of Bologna, Italy.

PMID: 20658590
DOI: 10.1002/ajh.21719

No abstract available

PubMed Disclaimer

Similar articles

Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
Hartz B, Löbel U, Hagel C, Escherich G. Hartz B, et al. Am J Hematol. 2013 Dec;88(12):1096-7. doi: 10.1002/ajh.23550. Epub 2013 Sep 12. Am J Hematol. 2013. PMID: 23873785 No abstract available.
Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia.
Gollard RP, Selco S. Gollard RP, et al. J Clin Oncol. 2013 Jul 1;31(19):e327-31. doi: 10.1200/JCO.2012.45.4728. Epub 2013 May 28. J Clin Oncol. 2013. PMID: 23715575 No abstract available.
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
McGregor BA, Brown AW, Osswald MB, Savona MR. McGregor BA, et al. Am J Hematol. 2009 Apr;84(4):228-30. doi: 10.1002/ajh.21365. Am J Hematol. 2009. PMID: 19260120 Review.
Skin manifestation of extramedullary relapse in adult with acute lymphoblastic leukaemia.
Rudzka E, Holowiecki J, Kachel L, Lawniczek T, Pajak J. Rudzka E, et al. Haematologia (Budap). 1991;24(4):235-9. Haematologia (Budap). 1991. PMID: 1844232
Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
DeAngelo DJ. DeAngelo DJ. Hematol Oncol Clin North Am. 2009 Oct;23(5):1121-35, vii-viii. doi: 10.1016/j.hoc.2009.07.008. Hematol Oncol Clin North Am. 2009. PMID: 19825456 Review.

See all similar articles

Cited by

Peripheral Nervous System Involvement in Non-Primary Pediatric Cancer: From Neurotoxicity to Possible Etiologies.
Pro S, Vinti L, Boni A, Mastronuzzi A, Scilipoti M, Velardi M, Caroleo AM, Farina E, Badolato F, Alessi I, Di Nardo G, Carai A, Valeriani M, Reale A, Parisi P, Raucci U. Pro S, et al. J Clin Med. 2021 Jul 6;10(14):3016. doi: 10.3390/jcm10143016. J Clin Med. 2021. PMID: 34300182 Free PMC article. Review.
Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis.
Kathpalia M, Mishra P, Bajpai R, Bhurani D, Agarwal N. Kathpalia M, et al. Ann Hematol. 2022 Aug;101(8):1655-1666. doi: 10.1007/s00277-022-04880-1. Epub 2022 Jun 21. Ann Hematol. 2022. PMID: 35727338
Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases.
Fukuta T, Tanaka T, Hashimoto T, Isahaya K, Kubo Y, Yamano Y, Satomi K, Hiraoka N, Shirakawa N, Arakawa A, Ogawa C, Nishimura N, Aoki J, Ito A, Inamoto Y, Kim SW, Fukuda T. Fukuta T, et al. Int J Hematol. 2023 Jun;117(6):933-940. doi: 10.1007/s12185-023-03539-5. Epub 2023 Jan 27. Int J Hematol. 2023. PMID: 36705847
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
Lonetti A, Cappellini A, Bertaina A, Locatelli F, Pession A, Buontempo F, Evangelisti C, Evangelisti C, Orsini E, Zambonin L, Neri LM, Martelli AM, Chiarini F. Lonetti A, et al. J Hematol Oncol. 2016 Oct 24;9(1):114. doi: 10.1186/s13045-016-0344-4. J Hematol Oncol. 2016. PMID: 27776559 Free PMC article.
Nelarabine in the treatment of refractory T-cell malignancies.
Roecker AM, Stockert A, Kisor DF. Roecker AM, et al. Clin Med Insights Oncol. 2010 Dec 1;4:133-41. doi: 10.4137/CMO.S4364. Clin Med Insights Oncol. 2010. PMID: 21151585 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley